Program Directors

Steering Committee

Drs. Napel and Sommer will initially appoint the Steering Committee (SC), which consists of themselves and 4 Program Faculty, who will serve for two years.  

Professor of Radiology (General Radiology) and, by courtesy, of Medicine (Medical Informatics) and of Electrical Engineering

Graham Sommer, MD

Professor of Radiology



Professor of Pediatrics (Neonatology), of Microbiology and Immunology and, by courtesy, of Radiology and of Bioengineering
Professor of Radiology (General Radiology) and, by courtesy, of Bioengineering and of Electrical Engineering
Professor of Radiology (General Radiology) and, by courtesy, of Electrical Engineering
Professor of Radiology (General Radiology)

Advisory Committee

We have assembled an outstanding Advisory Committee, which meets annually, consisting of both Stanford faculty and external advisors.

Sanjiv Sam Gambhir, MD, PhD

Professor and Chair of the Department of Radiology
Professor of Bioengineering and Materials Science & Engineering (by courtesy)
Director of the Molecular Imaging Program at Stanford (MIPS)
Director of the Canary Center at Stanford for Cancer Early Detection

Dr. Gambhir is world-renowned for his contributions to cancer imaging. He brings this experience, as well as that from having directed several training programs, including a multidisciplinary R25T (Stanford Molecular Imaging Scholars (SMIS). He also provides important links to clinical programs in oncological imaging research.

Gary Glover, PhD

Professor of Radiology, Neurosciences & Biophysics
Professor of Electrical Engineering and Psychology (by courtesy) 
Director, Radiological Sciences Laboratory

Dr. Glover is a leading expert in MR imaging and its applications. In addition, he brings almost 20 years of experience in this T32 training program, and management experience from directing the Radiological Sciences Laboratory and a large NCRR Research Resource funded via the P41 mechanism, the Center for Advanced Magnetic Resonance Technology (CAMRT) at Stanford.

Susan Knox, MD

Associate Professor of Radiation Oncology - Radiation Therapy

Dr. Knox specializes in cancer therapy, specifically radioimmunotherapy, and has been on the Advisory Committee for 11 years. She has been of great service to our program, providing a vital link to the needs on the therapy side of cancer imaging. Dr. Knox also has several years of experience leading clinical trials. Through her experience as PI and mentor for clinical trials she will be able to advise, in particular, in areas of translational research.

Norbert Pelc, ScD

Professor of Radiology and Bioengineering
Chair of Bioengineering

He has been active in diagnostic imaging research for more than 35 years, having made major contributions to CT, MR, ultrasound, x-ray, and nuclear medicine imaging. He has almost 20 years of experience in this T32 training program, and has mentored many pre- and postdoctoral fellows, many of whom have gone on to successful careers in academia and industry. In addition, he leads a T32 (Training In Biomedical Imaging Instrumentation - TBI2) that focuses on pre-doctoral training.

Yvonne (Bonnie) Maldonado, MD

Professor of Pediatrics (Infectious Diseases) and of Health Research and Policy
Senior Associate Dean for Faculty Development and Diversity in the School of Medicine


Michael McNitt-Gray, PhD

Professor of Radiology, David Geffen School Medicine at UCLA

Dr. McNitt-Gray brings his experience as the Program Director of the UCLA Biomedical Physics Graduate Program, an interdisciplinary program supported for over 35 years with an NIH T32 training grant. He has also devoted much of his research career to understanding and improving the detection of lung cancer using imaging.

John Gore, PhD

Professor of Molecular Physiology and Biophysics, Radiology and Radiological Sciences, Biomedical Engineering and Physics and Astronomy, Vanderbilt University Institute of Imaging Science

Dr. Gore brings experience directing both R25T and T32 NCI supported Training Programs, and has been active in the development of imaging methods for over 35 years, more recently focusing on the development of imaging biomarkers in cancer.